Provided by Tiger Trade Technology Pte. Ltd.

Provident

22.58
+0.23001.03%
Post-market: 22.580.00000.00%19:30 EDT
Volume:945.16K
Turnover:21.31M
Market Cap:2.95B
PE:9.42
High:22.69
Open:22.51
Low:22.39
Close:22.35
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:1.01
T/O Rate:0.75%
Dividend:0.96
Dividend Rate:4.25%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.01
PE(LYR):10.12

Loading ...

Provident Financial Services shareholders elect four directors at annual meeting

Reuters
·
May 22

2026 ASCO | Pivotal Data of InnoCare's Novel BCL2 Inhibitor Mesutoclax Released

GlobeNewswire
·
May 22

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

GlobeNewswire
·
May 22

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

GlobeNewswire
·
May 22

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026

GlobeNewswire
·
May 22

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

GlobeNewswire
·
May 22

Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC

GlobeNewswire
·
May 22

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy

GlobeNewswire
·
May 22

Kinterra Capital Secures US$75 Million to Advance White Pine Copper to FID Following PFS Progress and Royalty Framework Update

prnewswire
·
May 20

Anson Resources Completes Pre-Feasibility Study for US Lithium Project, Shares Fall 6%

MT Newswires Live
·
May 19

Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma

GlobeNewswire
·
May 16

Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

Benzinga
·
May 16

GT Biopharma Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 15

Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 15

Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update

GlobeNewswire
·
May 15

Inflation, Debt, and a Housing Standstill: Provident Bank's 2026 Consumer Survey Captures the State of American Household Finances

GlobeNewswire
·
May 14

USA Rare Earth Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 14

Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update

GlobeNewswire
·
May 14

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

GlobeNewswire
·
May 13